C1orf112 promotes breast cancer growth by modulating the cell cycle

C1orf112 contributes to breast cancer progression in association with cell cycle pathways, making it a potential diagnostic and therapeutic target with clinical applications.

Authors

Institutions

Publication Details

Journal
Frontiers in Bioengineering and Biotechnology
Published
2026-03-09
DOI
https://doi.org/10.3389/fbioe.2026.1717768
Primary Topic
Cancer-related Molecular Pathways
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

C1orf112 promotes breast cancer growth by modulating the cell cycle

Fengfeng Cai, Manuel A. Luis, Liyun Yong, Dongyang Liu et al.
Frontiers in Bioengineering and Biotechnology
Cancer-related Molecular Pathways
article

C1orf112 promotes breast cancer growth by modulating the cell cycle

Fengfeng Cai, Manuel A. Luis, Liyun Yong, Dongyang Liu, Shasha Tang, Xiaoxuan Zhu, Lingli Jin, Yuan Fang, Yikai Zheng
article en

Abstract

C1orf112 contributes to breast cancer progression in association with cell cycle pathways, making it a potential diagnostic and therapeutic target with clinical applications.

Frontiers in Bioengineering and BiotechnologyVol. 14
Tongji University (CN), Tongji Hospital (CN)
Tongji University
Quality Education
Openalex Percentile: Top 28%
Cancer-related Molecular Pathways
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.